Docetaxel: all 1,319 studies that test it
Page 11 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerCompletedNCT00321633Phase 2
- Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast CancerCompletedNCT00319618Phase 2
- Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLCCompletedNCT00319514Phase 2
- Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal CancerCompletedNCT00318903Phase 2
- Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and NeckCompletedNCT00318890Phase 1/2
- Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung CancerTerminatedNCT00315211Phase 2
- Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.CompletedNCT00314977Phase 3
- Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung CancerWithdrawnNCT00313690Phase 1/2
- PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPCTerminatedNCT00313482Phase 2
- Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00310154Phase 1
- AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast CancerCompletedNCT00310089Not applicable
- Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by GemcitabineCompletedNCT00294385Phase 3
- Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate CancerTerminatedNCT00293371Phase 1/2
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- An Open, Randomized, Multicentre, Phase II Pilot StudyCompletedNCT00293085Phase 2
- Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerCompletedNCT00290966Phase 2/3
- Interaction of Docetaxel and Lonafarnib in Patients With Advanced CancerTerminatedNCT00288444Phase 1
- Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerCompletedNCT00287885Phase 1
- Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric CancerCompletedNCT00287768Phase 3
- A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic IrradiationTerminatedNCT00285415Phase 2
- Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By SurgeryCompletedNCT00281970Phase 2
- Docetaxel in the Treatment of Hormone Refractory Prostate CancerCompletedNCT00280098Phase 4
- Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00278460Phase 2
- A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With TaxanesCompletedNCT00277043Phase 3
- Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue SarcomaCompletedNCT00276055Phase 1
- Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck CancerCompletedNCT00273546Phase 3
- DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])TerminatedNCT00273338Phase 3
- Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC PatientsTerminatedNCT00271323Phase 2
- A Study of Weekly Docetaxel Plus Cisplatin Followed by Gemcitabine vs. Gemcitabine Plus Cisplatin Followed by Weekly Docetaxel in the Treatment of Advanced Non-Small-Cell Lung CancerStatus unknownNCT00270582Phase 2
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric CancerStatus unknownNCT00270543Phase 2
- Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsCompletedNCT00268918Phase 1
- The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary CancerCompletedNCT00268840Phase 2
- Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]CompletedNCT00268710Phase 2
- Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)CompletedNCT00268671Phase 1/2
- Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate CancerCompletedNCT00268593Phase 2
- Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyActive, not recruitingNCT00268476Phase 2/3
- S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the OropharynxTerminatedNCT00268372Phase 3
- Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung CancerTerminatedNCT00264134Phase 1/2
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00263016Phase 2
- Study of Oxaliplatin and Taxotere in Prostate CancerCompletedNCT00260611Phase 2
- Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung CancerCompletedNCT00260026Phase 2
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00258739Phase 2
- OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00258375Phase 2
- Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00258284Phase 2
- Capecitabine and Docetaxel in Advanced/Recurrent Cervical CancerCompletedNCT00257348Phase 2
- Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate CancerCompletedNCT00255606Phase 3
- Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following SurgeryCompletedNCT00254384Phase 1
- Lenalidomide and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00253344Phase 1
- RAD001 Plus Docetaxel in Patients With Metastatic Breast CancerTerminatedNCT00253318Phase 1
- GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast CancerTerminatedNCT00251433Phase 1
- Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor MalignanciesCompletedNCT00251407Phase 1
- Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone MarrowCompletedNCT00248703Phase 2
- ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast CancerCompletedNCT00247481Phase 2
- Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNCT00243204Phase 3
- Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or HypopharynxCompletedNCT00243113Phase 2
- Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerCompletedNCT00242918Phase 2
- ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck CancerCompletedNCT00242762Phase 2
- Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By SurgeryCompletedNCT00238407Phase 2
- Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic CancerCompletedNCT00238199Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal CancerCompletedNCT00238147Phase 1
- Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung CancerTerminatedNCT00232206Phase 2
- Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) CancersCompletedNCT00231855Phase 2
- Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00227708Phase 2
- Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue LeiomyosarcomaCompletedNCT00227669Phase 2
- Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast CarcinomaTerminatedNCT00225056Phase 2
- Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung CancerCompletedNCT00222144Phase 2
- Preliminary Study of Mycograb and Docetaxel in Advanced Breast CancerCompletedNCT00217815Phase 1/2
- Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity CancerCompletedNCT00217568Phase 2
- Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerCompletedNCT00217529Phase 1/2
- Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & NeckTerminatedNCT00216138Phase 2
- Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian CancerCompletedNCT00216112Phase 2
- Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.TerminatedNCT00216008Phase 2
- Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate CancerCompletedNCT00215709Phase 1
- A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate CancerStatus unknownNCT00215345Phase 2
- A Study of Weekly Taxotere and Xeloda in Metastatic Breast CancerCompletedNCT00214864Phase 2
- Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal CancerCompletedNCT00214058Phase 2
- Docetaxel Combined With Ketoconazole in Treatment of Breast CancerCompletedNCT00212095Phase 2
- Gene Expression Profiles in Predicting Chemotherapy Response in Breast CancerCompletedNCT00212082Phase 2
- Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.SuspendedNCT00209729Phase 1/2
- Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.CompletedNCT00209716Phase 1/2
- Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer.CompletedNCT00209690Phase 1/2
- Phase II Trial of Gleevec and Taxotere as a Combined Regimen for Advanced Gastric AdenocarcinomaTerminatedNCT00209079Phase 2
- Neoadjuvant TaxotereCompletedNCT00206505Phase 2
- Biologic Correlative Taxotere/ACCompletedNCT00206466Phase 2
- Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast CancerTerminatedNCT00206453Phase 2
- Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid TumorsCompletedNCT00201812Phase 1
- Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast CancerCompletedNCT00201708Phase 2
- Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IVCompletedNCT00198393Phase 2
- Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast CancerCompletedNCT00198237Phase 2
- Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast CancerCompletedNCT00194740Phase 2
- Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid TumorsCompletedNCT00193570Phase 1
- Weekly Docetaxel Versus Weekly Docetaxel/Gemcitabine in the Treatment of Non-Small Cell Lung Cancer in Elderly PatientsCompletedNCT00193323Phase 2
- Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate CancerCompletedNCT00193271Phase 2
- Oral Topotecan Versus Docetaxel in Second-Line Treatment of Non-Small Cell Lung CancerCompletedNCT00193245Phase 2
- Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate CancerCompletedNCT00193232Phase 2
- Docetaxel Followed by Doxorubicin Plus Cyclophosphamide for Node Positive or High-Risk Primary Breast CancerCompletedNCT00193115Phase 2
- Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast CancerCompletedNCT00193089Phase 2
- Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast CancerTerminatedNCT00193024Phase 2
- Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast CancerCompletedNCT00193011Phase 3
- A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast CancerCompletedNCT00191672Phase 2